Uswidi - Kiswidi - Läkemedelsverket (Medical Products Agency)

linepharma - mifepriston - tablett - 200 mg - mifepriston 200 mg aktiv substans - mifepriston

Uswidi - Kiswidi - Läkemedelsverket (Medical Products Agency)

zentiva k.s. - budesonid - suspension för nebulisator - 0,5 mg/ml - budesonid 0,5 mg aktiv substans

Umoja wa Ulaya - Kiswidi - EMA (European Medicines Agency)

axunio pharma gmbh - pirfenidon - idiopatisk lungfibros - immunsuppressiva - pirfenidone aet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Umoja wa Ulaya - Kiswidi - EMA (European Medicines Agency)

viatris limited - pirfenidon - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - immunsuppressiva - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Umoja wa Ulaya - Kiswidi - EMA (European Medicines Agency)

accord healthcare s.l.u. - abirateronacetat - prostatiska neoplasmer - endokrin terapi - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Umoja wa Ulaya - Kiswidi - EMA (European Medicines Agency)

mylan ireland limited - abirateronacetat - prostatiska neoplasmer - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Umoja wa Ulaya - Kiswidi - EMA (European Medicines Agency)

krka, d.d., novo mesto - abirateronacetat - prostatiska neoplasmer - endokrin terapi - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

Uswidi - Kiswidi - Läkemedelsverket (Medical Products Agency)

actavis group ptc ehf. - zopiklon - filmdragerad tablett - 5 mg - laktosmonohydrat hjälpämne; zopiklon 5 mg aktiv substans - zopiklon

Uswidi - Kiswidi - Läkemedelsverket (Medical Products Agency)

actavis group ptc ehf. - zopiklon - filmdragerad tablett - 7,5 mg - laktosmonohydrat hjälpämne; zopiklon 7,5 mg aktiv substans - zopiklon

Uswidi - Kiswidi - Läkemedelsverket (Medical Products Agency)

sandoz a/s - pirfenidon - filmdragerad tablett - 267 mg - pirfenidon 267 mg aktiv substans